|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows From Operating Activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Stock based compensation | |||||
| Depreciation and amortization | |||||
| Impairment of property & equipment | |||||
| Loss on lease termination | |||||
| Loss on sale of property & equipment | |||||
| Loss on disposal of property & equipment | |||||
| Change of right-of-use asset | |||||
| Net change in fair value of marketable securities | |||||
| Gain on sale of R&D assets | |||||
| Amortization of right-of-use asset | |||||
| Change in inventory reserve | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Operating lease liabilities | |||||
| Contract liabilities | |||||
| Net cash used in operating activities | |||||
| Cash Flows From Investing Activities | |||||
| Security deposit | |||||
| Net (purchases) sales of investment in trading marketable securities | |||||
| Realized gain on sale of marketable securities, available for sale | |||||
| Net sales of investment in marketable securities | |||||
| Proceeds from sale of property & equipment | |||||
| Purchase of property and equipment | |||||
| Net cash used in investing activities | |||||
| Cash Flows From Financing Activities | |||||
| Proceeds from issuance of common stock, net of fees of $444,899 | |||||
| Proceeds from Forza Issuance of common stock | |||||
| Deferred offering costs | |||||
| Forza stock repurchase | |||||
| Finance lease payments | |||||
| Net cash provided by (used in) financing activities | |||||
| Net change in cash, cash equivalents and restricted cash | |||||
| Cash and cash equivalents | |||||
| Cash, cash equivalents and restricted cash at beginning of the period | |||||
| Cash, cash equivalents and restricted cash at end of the period | |||||
| Supplemental Cash Flow Information | |||||
| Cash paid for interest | |||||
| Non-Cash Investing and Financing Activities | |||||
| Right of use asset - finance leases | |||||
| Sale of building in exchange for note receivable | |||||
| Reconciliation to the Consolidated Balance Sheets | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
| Total cash, cash equivalents and restricted cash | |||||
Loading...